Unsure which funding opportunity is right for you? Use our investor matching tool to help you on to your next step
Find investorsTakes less than ~2 min to complete
I am an experienced asset manager, and I have held several executive positions throughout the banking and investment industry. The key word for my career has been client focus and a tireless development of the business potential, combined with a deep knowledge of the different elements in the asset management products, and a focus on the risk management and administrative set up. I belive in attracting skilled people by practicing an inclusive management style
I am a passionate and disciplined entrepreneur with years of experience driving impactful start-ups to international growth and successful exits. I am driven by making a difference in the world and am impatient by nature. I stand on a strong family foundation, which provides the support needed to give my all to ensuring companies succeed.
We are a Copenhagen based venture capital company, investing in outstanding ICT companies with proof of product, 1st. class management and scalable business models. We work actively to ignite and enhance growth within our portfolio companies - through business development, internationalization and acquisitions Over the last 10 years we have executed more than 40 investment cycles, transforming companies – and eventually exited our investments through trade sales or market listings.
Please go to https://www.herlevhospital.dk/ccit-denmark/Sider/default.aspx for more information. In short CCIT comprise clinical and experimental expertise in tumor immunology. The Centre has approx. 25 employees; scientists, clinicians, PhD students, as well as technicians. The Centre has extensive experience in initiating clinical trials in cancer, and more than 100 cancer patients have been vaccinated with dendritic cell based therapeutic vaccinations and new facilities for GCP production of cellular products for clinical use was recently opened, enabling trials using adoptive cell transfer of tumor specific T cells.